VRNA
Geode Capital Management’s Verona Pharma VRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.47M | Buy |
68,430
+10,757
| +19% | +$1.02M | ﹤0.01% | 2597 |
|
2025
Q1 | $3.66M | Sell |
57,673
-5,068
| -8% | -$322K | ﹤0.01% | 2812 |
|
2024
Q4 | $2.91M | Buy |
62,741
+660
| +1% | +$30.7K | ﹤0.01% | 2993 |
|
2024
Q3 | $1.79M | Sell |
62,081
-3,863
| -6% | -$111K | ﹤0.01% | 3163 |
|
2024
Q2 | $954K | Buy |
65,944
+572
| +0.9% | +$8.27K | ﹤0.01% | 3325 |
|
2024
Q1 | $1.05M | Buy |
65,372
+4,259
| +7% | +$68.5K | ﹤0.01% | 3343 |
|
2023
Q4 | $1.21M | Buy |
61,113
+8,624
| +16% | +$171K | ﹤0.01% | 3277 |
|
2023
Q3 | $856K | Buy |
52,489
+7,497
| +17% | +$122K | ﹤0.01% | 3392 |
|
2023
Q2 | $951K | Buy |
44,992
+12,202
| +37% | +$258K | ﹤0.01% | 3381 |
|
2023
Q1 | $658K | Buy |
32,790
+1,136
| +4% | +$22.8K | ﹤0.01% | 3546 |
|
2022
Q4 | $827K | Sell |
31,654
-10,696
| -25% | -$279K | ﹤0.01% | 3444 |
|
2022
Q3 | $432K | Buy |
42,350
+27,913
| +193% | +$285K | ﹤0.01% | 3794 |
|
2022
Q2 | $60K | Hold |
14,437
| – | – | ﹤0.01% | 4735 |
|
2022
Q1 | $72K | Buy |
14,437
+1,164
| +9% | +$5.81K | ﹤0.01% | 4740 |
|
2021
Q4 | $89K | Buy |
13,273
+2,566
| +24% | +$17.2K | ﹤0.01% | 4759 |
|
2021
Q3 | $58K | Buy |
+10,707
| New | +$58K | ﹤0.01% | 4763 |
|